Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Parental Consent May Soon Be Required for Minor Mental Health Services in Ohio

Client Alert
June 25, 2025

HB 172 seeks to repeal ORC Section 5122.04, which permits mental health professionals to provide outpatient mental health services to minors ages fourteen (14) or older without parent/guardian knowledge or consent. Under current Ohio law, minors can consent to no more than six (6) sessions or thirty (30) days of mental health services, whichever occurs sooner. The repeal would require parental consent for minors ages fourteen (14) or older to receive outpatient mental health services.

HB 172 also seeks to remove language from ORC Section 3129.03 referencing ORC Section 5122.04 which, under the bill, would now mandate parent/guardian consent in all situations when a mental health professional is diagnosing or treating a gender-related condition without the existence of any statutory exception. Eliminating ORC Section 5122.04 would compromise the confidentiality of a minor’s protected health information by allowing their parents to access information related to utilization of mental health services. HB 172 had its first hearing in the House Health Committee on May 21, 2025.

Please contact BMD Healthcare Member Daphne Kackloudis at dlkackloudis@bmdllc.com or Attorney Jordan Burdick at jaburdick@bmdllc.com with any questions you may have regarding the potential impacts from this policy change.

Health LawHealthcareMental HealthDaphne KackloudisJordan Burdick
Client Alert

Compounding GLP-1 Drugs - Recent Updates

November 13, 2025Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.Client Alert

Top Compliance Risks for Ohio Med-Spas in 2025

November 11, 2025The Ohio Board of Pharmacy has increased inspections of med-spas holding Terminal Distributor of Dangerous Drugs (TDDD) licenses, with many facing enforcement actions in 2025. Common issues include purchasing from unlicensed distributors, improper drug storage, inadequate recordkeeping, and insufficient prescriber oversight. Understanding these risks and maintaining compliance can help protect your practice from penalties and license suspension.Client Alert

Pre and Postnuptial Agreements | Necessary, Maybe, What Happened to Forever?

November 7, 2025Both Florida and Ohio now allow clients to enter into a prenuptial or postnuptial agreement prior to marriage or after marriage (Ohio previously did not allow postnuptial agreements). Both documents have statutory guidelines that must be followed in terms of execution and financial disclosure.Client Alert

DHS Ends All Employment Authorization Auto-Extensions

October 29, 2025Effective October 30, 2025, DHS ends all automatic work authorization renewals. The 540-day extension applies only to renewals filed before this date, and there is no grace period for expired EADs filed on or after October 30. Employers must audit EADs, train staff, ensure I-9 compliance, and plan for work authorization gaps. Penalties for noncompliance can be severe.Client Alert

CMS’s Rural Health Funding Announcement

October 27, 2025CMS has announced a $50 billion Rural Health Transformation (RHT) Program to improve healthcare access, quality, and outcomes in rural communities. All states are eligible to apply for funding by November 5, 2025. Half of the funds will be distributed equally, with the remainder based on state-specific factors. The program supports evidence-based initiatives, workforce recruitment, and access to treatment services, with awards assessed annually
Older posts
Newer posts